Dr Agarwals Eye Hospital Achieves All-Time High Stock Price on December 18, 2024 - MarketsMojo
| LOTUSEYE | 67.84 3.10 4.37% |
Slightly above 62% of Lotus Eye's investor base is looking to short. The analysis of overall sentiment of trading Lotus Eye Hospital stock suggests that many investors are alarmed at this time. Lotus Eye's investing sentiment can be driven by a variety of factors including economic data, Lotus Eye's earnings reports, geopolitical events, and overall market trends.
Lotus |
Dr Agarwals Eye Hospital Achieves All-Time High Stock Price on December 18, 2024 MarketsMojo
Read at news.google.com
 |
Lotus Eye Fundamental Analysis
We analyze Lotus Eye's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Eye based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Lotus Eye is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Lotus Eye Hospital Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lotus Eye stock to make a market-neutral strategy. Peer analysis of Lotus Eye could also be used in its relative valuation, which is a method of valuing Lotus Eye by comparing valuation metrics with similar companies.
Peers
Lotus Eye Related Equities
| NEWGEN | Newgen Software | 3.40 | ||||
| MELSTAR | Melstar Information | 0.00 | ||||
| AVALON | AVALON TECHNOLOGIES | 0.31 | ||||
| FCSSOFT | FCS Software | 1.45 | ||||
| SELAN | Selan Exploration | 3.78 | ||||
| CTE | Cambridge Technology | 4.79 | ||||
| ARROWGREEN | Arrow Greentech | 4.80 | ||||
| DHANUKA | Dhanuka Agritech | 4.90 |
Additional Tools for Lotus Stock Analysis
When running Lotus Eye's price analysis, check to measure Lotus Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Eye is operating at the current time. Most of Lotus Eye's value examination focuses on studying past and present price action to predict the probability of Lotus Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Eye's price. Additionally, you may evaluate how the addition of Lotus Eye to your portfolios can decrease your overall portfolio volatility.